| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 147 | 43.253 | 229 | 291 | 2.365 | 7.468 |
| Total Income - EUR | - | - | - | 0 | 147 | 43.253 | 229 | 291 | 2.365 | 7.468 |
| Total Expenses - EUR | - | - | - | 2.604 | 27.151 | 36.587 | 24.721 | 15.263 | 12.032 | 18.450 |
| Gross Profit/Loss - EUR | - | - | - | -2.604 | -27.004 | 6.666 | -24.491 | -14.972 | -9.667 | -10.982 |
| Net Profit/Loss - EUR | - | - | - | -2.604 | -27.005 | 6.235 | -24.494 | -14.975 | -9.691 | -11.206 |
| Employees | - | - | - | 1 | 2 | 3 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Mlm Ambumedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 6.746 | 4.958 |
| Current Assets | - | - | - | 42 | 573 | 674 | 1.135 | 1.330 | 1.028 | 136 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 1.078 | 1.279 | 0 | 0 |
| Cash | - | - | - | 42 | 573 | 674 | 57 | 52 | 1.028 | 136 |
| Shareholders Funds | - | - | - | -2.561 | -29.508 | -22.713 | -46.703 | -61.822 | -71.325 | -82.133 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.603 | 30.080 | 23.387 | 47.838 | 63.153 | 79.100 | 87.228 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Mlm Ambumedica S.r.l.